Diabetes symptom relief through a laser based medical device
First Claim
Patent Images
1. A method comprising:
- generating a first soliton wave through a laser diode of a first medical instrument at a wavelength of approximately 660 nm to 808 nm;
generating a second soliton wave through a laser diode of a second medical instrument at a wavelength of approximately 660 nm to 808 nm;
applying the first soliton wave to a first application point located over the left kidney of a patient suffering from Type I or Type II diabetes on the small of the patient'"'"'s back, one hand width above the belt and one hand width to the left of the spine, for a one minute duration;
repeating the application of the first soliton wave to the first application point for the one minute duration two more times in the same day;
applying the second soliton wave to a second application point located over the extreme outer edge of the patient'"'"'s inner elbow crease, for a one minute duration;
repeating the application of the second soliton wave to the second application point for the one minute duration two more times in the same day;
coordinating the application of the first soliton wave and the second soliton wave through an algorithm that controls the generation of the first soliton wave of the first medical instrument and the generation of the second soliton wave of the second medical instrument; and
reducing a glycosylated hemoglobin Alc (HbAlc) of the patient as a result of the application of the first soliton wave and the second soliton wave.
2 Assignments
0 Petitions
Accused Products
Abstract
Disclosed are several methods, apparatus, and a system for providing diabetic symptom relief through a laser based medical instrument. In one embodiment, a method includes generating a radiation of a laser-light created by a laser diode of a first medical instrument. In addition, the method includes applying a treatment of the radiation to a portion of a body. The method also includes reducing elevated blood glucose and/or glycosylated hemoglobin levels caused by one or more metabolic diseases such as diabetes. The method further includes providing a relief from the secondary complications of elevated blood glucose levels such as blurred vision, etc., when the treatment is complete.
11 Citations
4 Claims
-
1. A method comprising:
-
generating a first soliton wave through a laser diode of a first medical instrument at a wavelength of approximately 660 nm to 808 nm; generating a second soliton wave through a laser diode of a second medical instrument at a wavelength of approximately 660 nm to 808 nm; applying the first soliton wave to a first application point located over the left kidney of a patient suffering from Type I or Type II diabetes on the small of the patient'"'"'s back, one hand width above the belt and one hand width to the left of the spine, for a one minute duration; repeating the application of the first soliton wave to the first application point for the one minute duration two more times in the same day; applying the second soliton wave to a second application point located over the extreme outer edge of the patient'"'"'s inner elbow crease, for a one minute duration; repeating the application of the second soliton wave to the second application point for the one minute duration two more times in the same day; coordinating the application of the first soliton wave and the second soliton wave through an algorithm that controls the generation of the first soliton wave of the first medical instrument and the generation of the second soliton wave of the second medical instrument; and reducing a glycosylated hemoglobin Alc (HbAlc) of the patient as a result of the application of the first soliton wave and the second soliton wave. - View Dependent Claims (2, 3, 4)
-
Specification